RZLT Rezolute, Inc.
$4.22▲ +1.20%
Healthcare
Other
After hours
$4.29▲ +1.66%
Sep 11, 7:43 PM ET
Volume 1.35M
Avg Volume (10D) 1.17M
Key Metrics & Fundamentals
Market Cap
$406.35M
P/E Ratio
–
Div Yield
–%
52W Range
1.07 - 11.46
% vs 50 MA
-11.08%
% vs 200 MA
5.23%
RSI-14
38.3
MACD Histogram
-0.0700
Beta (1Y vs SPY)
0.99
Free Cash Flow
-$13.74M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$17.36M
COGS
–
Operating Exp
$17.37M
Operating Income
-$17.37M
EBIT
-$17.37M
Pretax Income
-$16.17M
Net Income
-$16.17M
EPS (Diluted)
-0.16
Price & Volume History
Loading chart…
Recent News
Sector Update: Healthcare Stocks Softer Late Afternoon
MT Newswires · Sep 9, 2026 7:49 PM
Sector Update: Healthcare Stocks Decline in Afternoon Trading
MT Newswires · Sep 9, 2026 5:34 PM
Rezolute FDA Review Continues After Phase 3 sunRIZE Study Missed Primary Endpoint
InvestorsHub · Sep 9, 2026 2:43 PM
Rezolute Says FDA Still Reviewing Ersodetug Data From Phase 3 Congenital Hyperinsulinism Study
MT Newswires · Sep 9, 2026 12:30 PM
Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism
GlobeNewswire · Sep 9, 2026 11:00 AM
Rezolute to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 2, 2026 11:30 AM
Rezolute Shares to Show Strength Towards Upcoming Ersodetug Catalysts, Wedbush Says
MT Newswires · Aug 25, 2026 3:20 PM
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
GlobeNewswire · Jul 21, 2026 11:30 AM
Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society
GlobeNewswire · Jun 17, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See RZLT's money flow as a full page
Social Sentiment
No Reddit posts found for RZLT.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.